Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation.

Cancer research communications·2025
Same author

Author Correction: Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension.

Scientific reports·2025
Same author

CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibody.

mAbs·2024
Same author

Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension.

Scientific reports·2024
Same author

An Engineered Mouse Model That Generates a Diverse Repertoire of Endogenous, High-Affinity Common Light Chain Antibodies.

Antibodies (Basel, Switzerland)·2024
Same author

VHH CDR-H3 conformation is determined by VH germline usage.

Communications biology·2023

Related Experiment Video

Updated: May 3, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.2K

Selection and screening using antibody phage display libraries.

Patrick Koenig1, Germaine Fuh

  • 1Antibody Engineering Department, Genentech Inc., South San Francisco, CA, USA.

Methods in Molecular Biology (Clifton, N.J.)
|February 12, 2014
PubMed
Summary
This summary is machine-generated.

This study details a step-by-step protocol for phage display panning to isolate specific antibody binders. It covers antigen testing, optimizing conditions, and minimizing nonspecific binding for successful antibody discovery.

More Related Videos

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
12:31

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Published on: May 1, 2018

13.9K
A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits
12:36

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits

Published on: February 16, 2014

33.7K

Related Experiment Videos

Last Updated: May 3, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

18.2K
Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
12:31

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Published on: May 1, 2018

13.9K
A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits
12:36

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits

Published on: February 16, 2014

33.7K

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Phage display technology enables the isolation of specific binding molecules from vast combinatorial libraries.
  • Antibody discovery is crucial for therapeutic and diagnostic applications.

Purpose of the Study:

  • To provide a comprehensive, step-by-step protocol for establishing a successful phage display panning experiment.
  • To guide researchers in isolating high-affinity and specific antibody binders.

Main Methods:

  • Detailed protocol for phage panning, including library transformation and clone screening.
  • Methods for testing antigen suitability for phage panning.
  • Optimization strategies for panning conditions to reduce nonspecific binding.
  • Description of alternative screening methods.

Main Results:

  • A robust protocol for phage display panning is presented.
  • Key steps and optimization techniques for successful antibody isolation are outlined.
  • Example experiments demonstrate the process from library transformation to clone screening.

Conclusions:

  • The provided protocol facilitates the efficient isolation of specific antibody binders using phage display.
  • Optimized panning conditions and screening methods are essential for minimizing background and maximizing target-specific antibody recovery.